MANILA, Philippines — China’s Sinovac Biotech’s vaccine in opposition to COVID-19 isn’t the costliest and was offered at a “very good price” to the Philippines, one of many drugmaker’s officers mentioned Monday.
Sinovac Biotech General Supervisor Helen Yang mentioned the agency’s vaccine price is “reasonable” and it’s not the costliest nor the second costliest out there.
“That’s not the second most expensive, I can assure you. It is reasonable, I believe,” she mentioned in an interview on Fintech Zoom Philippines’ The Supply.
“I will be assuring you that this is a very good price that we have provided to the Philippines,” Yang added.
The assertion is in line with Malacañang earlier pronouncements that Sinovac’s vaccine isn’t the costliest, because the Philippines was given a “BFF” charge.
Presidential spokesman Harry Roque earlier mentioned Sinovac’s vaccine will solely value round P650 per dose.
Yang didn’t affirm the mentioned charge, however insisted that the price of the vaccine is affordable.
She likewise identified that purchasing the vaccine is just one think about the associated fee, different prices must also be thought-about comparable to logistics, transportation and storage of the vaccine.
Sinovac is already finalizing the time period sheet settlement with the Philippine authorities.
The Philippines has secured 25 million doses of the Sinovac’s vaccine for 2021, 50,000 of which can arrive within the nation in February.
Earlier than the vaccines are rolled out, nonetheless, Yang mentioned the nation’s Meals and Drug Administration should first approve the product for emergency use, Yang mentioned.
Sinovac has utilized for an emergency use authorization this month.